title: Antenatal Bartter's syndrome: why is this not a lethal condition?
abstract: There are four themes in this teaching exercise for Professor McCance. The first challenge was to explain how a premature infant with Bartter's syndrome could survive despite having such a severe degree of renal salt wasting. Second, the medical team wanted to know why there was such a dramatic decrease in the natriuresis in response to therapy, despite the presence of a permanent molecular defect that affected the loop of Henle. Third, Professor McCance was asked why this patient seemed to have a second rare disease, AQP2 deficiency type of nephrogenic diabetes insipidus. The fourth challenge was to develop a diagnostic test to help the parents of this baby titrate the dose of indomethacin to ensure an effective dose while minimizing the likelihood of developing nephrotoxicity. The missing links in this interesting story emerge during a discussion between the medical team and its mentor.
authors.affiliation: Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London WC1N 3JH, UK. detlef.bockenhauer@nhs.net
authors.forename: D
authors.initials: D
authors.lastname: Bockenhauer
authors.forename: M
authors.initials: M
authors.lastname: Cruwys
authors.forename: R
authors.initials: R
authors.lastname: Kleta
authors.forename: L F
authors.initials: LF
authors.lastname: Halperin
authors.forename: P
authors.initials: P
authors.lastname: Wildgoose
authors.forename: T
authors.initials: T
authors.lastname: Souma
authors.forename: N
authors.initials: N
authors.lastname: Nukiwa
authors.forename: S
authors.initials: S
authors.lastname: Cheema-Dhadli
authors.forename: C K
authors.initials: CK
authors.lastname: Chong
authors.forename: K S
authors.initials: KS
authors.lastname: Kamel
authors.forename: M R
authors.initials: MR
authors.lastname: Davids
authors.forename: M L
authors.initials: ML
authors.lastname: Halperin
mesh_terms: D000818:Animals; D051398:Aquaporin 1 / Q000172:deficiency; D001477:Bartter Syndrome / Q000150:complications* / Q000151:congenital / Q000628:therapy; D002712:Chlorides / Q000652:urine; D018500:Diabetes Insipidus, Nephrogenic / Q000175:diagnosis* / Q000188:drug therapy; D006801:Humans; D006929:Hyperaldosteronism / Q000209:etiology*; D007213:Indomethacin / Q000008:administration & dosage; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007674:Kidney Diseases / Q000175:diagnosis / Q000503:physiopathology; D008138:Loop of Henle / Q000502:physiology; D008297:Male; D051381:Rats; D012964:Sodium / Q000378:metabolism* / Q000652:urine
chemical_list: D002712:Chlorides; D051398:Aquaporin 1; D012964:Sodium; D007213:Indomethacin